Clinical Safety

The development of new medicines for the most critically ill patients is a path fraught with immense challenges, where promising breakthroughs can be abruptly overshadowed by unforeseen safety concerns. In a significant and unexpected development, London-based biopharmaceutical company Pulmocide

A groundbreaking study has decisively answered a question at the forefront of modern medicine, confirming that a cancer treatment tailored to the unique genetic fingerprint of a patient's tumor is not only possible but also significantly more effective and safe than conventional approaches.

The persistent feeling of being physically older and less resilient following a serious illness is no longer just a subjective complaint but is now understood as a tangible biological process driven by cellular damage. Many who recover from infections like influenza or COVID-19 report lingering

A significant portion of cancer patients do not respond to immunotherapy because their tumors are immunologically inactive, but a groundbreaking collaborative study from Cornell University researchers has unveiled a remarkable solution using ultrasmall fluorescent silica nanoparticles, known as

For the millions of people battling chronic nerve pain, where the lightest touch can feel like a searing burn, hope often feels distant. But a groundbreaking study is challenging the way we think about pain, shifting the focus from masking symptoms to repairing the damage at a cellular level. To

A groundbreaking therapy capable of halting one of the most aggressive forms of cancer has long been shadowed by a side effect so severe that it forces patients to abandon their best hope for survival. This paradox has defined the initial chapter of PSMA-targeted radioligand therapy, a significant